Latest Insider Transactions at Beam Therapeutics Inc. (BEAM)
This section provides a real-time view of insider transactions for Beam Therapeutics Inc. (BEAM). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Beam Therapeutics Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Beam Therapeutics Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 10
2020
|
Kristina Burow |
BUY
Conversion of derivative security
|
Indirect |
8,243,039
+50.0%
|
-
|
|
Feb 10
2020
|
Robert Nelsen Director |
BUY
Conversion of derivative security
|
Indirect |
8,243,039
+50.0%
|
-
|
|
Feb 10
2020
|
Mark Fishman |
BUY
Conversion of derivative security
|
Direct |
17,007
+50.0%
|
-
|
|
Feb 10
2020
|
Redmile Group, LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
1,161,458
+50.0%
|
-
|